Cardiovascular Responses to Spartathlon Running

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-09-29

Study Completion Date

2021-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to examine the cardiovascular effects of ultramarathon running and their relation to performance.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Investigation of Cardiac Function and Cardiovascular Risk Factors in Marathon Runners- The Munich Marathon Study

NCT00500773

Modes of Exercise and Myocardial and Endothelial Function Microcirculation Subclinical Endorgan Damage +1 more

COMPLETED

Acute Cardiac Dysfunction in Critical Illnes

NCT05860504

Multi Organ Failure Left Ventricular Dysfunction Right Ventricular Dysfunction +3 more

RECRUITING

Post Thyroidectomy Myocardial Function

NCT03060499

Thyroid Thyroidectomy Myocardial Function

WITHDRAWN

Myocardial Infarction in the Perioperative Setting

NCT03837535

Myocardial Infarction Postoperative Myocardial Injury Intraoperative Complications +2 more

COMPLETED

AOrtic Surgery: Systemic Inflammatory Response Versus Sepsis

NCT06028789

Systemic Inflammatory Response Syndrome Infections Thoracic Aortic Aneurysm +2 more

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of the study is to determine the changes of cardiovascular morphology and function after an ultramarathon race. 50 entrants to the "Spartathlon 2017" 246-km running race will participate in the study. Cardiac and arterial morphology and function tests will be conducted one day before the race and within 20 minutes of race completion.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Disorder Heart

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

athletes participating in the ultra marathon running

Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Before and after the race

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Athletes

246-km running

Group Type EXPERIMENTAL

246-km running

Intervention Type OTHER

Spartathlon 2017

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

246-km running

Spartathlon 2017

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Runners at least 18 years old, healthy and sufficiently trained.
* Runners being accepted to participate in the Spartathlon race according to the eligibility criteria (http://www.spartathlon.gr/en/registration-en.html)
* Runners who will volunteer to be examined pre- and post the race